Immune-related adverse events predict responses to PD-1 blockade immunotherapy in hepatocellular carcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Lianghe,Lu

第一单位： Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.

作者： Lianghe,Lu ^[1] ; Kaili,Xing ^[2] ; Wei,Wei ^[1] ; Yihong,Ling ^[3] ; Peng,Li ^[1] ; Shaohua,Li ^[2] ; Yan,Wang ^[1] ; Dan,Xie ^[4] ; Rongping,Guo ^[1] ; Muyan,Cai ^[4]

作者单位： Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China. ^[1] Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. ^[2] Department of Pancreatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China. ^[3] Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China. ^[4] Department of Pathology, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China. ^[5]

关键词 anti-PD-1 antibodies hepatocellular carcinoma immune-related adverse events prognosis tumor response

DOI 10.1002/ijc.33609

PMID 33890283

发布时间 2024-02-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

International journal of cancer

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Immune-related adverse events predict responses to PD-1 blockade immunotherapy in hepatocellular carcinoma.

International journal of cancer

相似文献

International journal of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Immune-related adverse events predict responses to PD-1 blockade immunotherapy in hepatocellular carcinoma.

International journal of cancer

相似文献

International journal of cancer

相关期刊

检索历史清除